HTLV-1 infection and health outcomes

dc.contributor.author	Ramos, José M.
dc.contributor.author	Mendoza, Carmen de
dc.contributor.author	Soriano, Vicente
dc.date	2020-04
dc.date.accessioned	2020-08-05T09:25:16Z
dc.date.available	2020-08-05T09:25:16Z
dc.identifier.issn	1473-3099
dc.identifier.uri	https://reunir.unir.net/handle/123456789/10344
dc.description.abstract	The meta-analysis published by Gill Schierhout and colleagues1 reported an increased relative risk of premature death in individuals infected with HTLV-1 compared with individuals not infected with HTLV-1 (RR 1·57, 95% CI 1·37–1·80). This risk was independent of adult T-cell leukaemia-lymphoma (ATL) and HTLV-1-associated myelopathy (HAM), also called tropical spastic paraparesis (TSP), the two well known diseases associated with HTLV-1. In their systematic search, the authors identified a broader number of illnesses that were significantly more prevalent in individuals infected with HTLV-1 and that could contribute to the poorer survival of these individuals.	es_ES
dc.language.iso	eng	es_ES
dc.publisher	The Lancet Infectious Diseases	es_ES
dc.relation.ispartofseries	;vol. 20, nº 4
dc.relation.uri	https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30133-X/fulltext	es_ES
dc.rights	openAccess	es_ES
dc.subject	HTLV-1 infection	es_ES
dc.subject	human	es_ES
dc.subject	Scopus	es_ES
dc.subject	JCR	es_ES
dc.title	HTLV-1 infection and health outcomes	es_ES
dc.type	Articulo Revista Indexada	es_ES
reunir.tag	~ARI	es_ES
dc.identifier.doi	https://doi.org/10.1016/S1473-3099(20)30133-X

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.